[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fPblpv08GGW_f0s3If1bMA7v6BKNi5iIg1ye5Wrav9iQ":8,"$fsibH4YRq2Bi0MC47Dekt0GxtAZn2oKa_FRxvmgJKfBU":55,"$fSLdGW9YwtvJI3poopzTAd1XA75VUGe-gVRnEcLuoYMs":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},59916,868961,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//XmlWYnxIH062cIbbHa7erStQOA85eS5D.png","杨丽丽","杭州师范大学附属医院","肿瘤科","住院医师",80,0,"了解弥漫大B细胞淋巴瘤：实用指南","","https://ystcdn.venuertc.com/venue/AI/8c5b03af-13d2-4d25-ae05-287b511dd529.jpg","\u003Ch2 id=\"material_title\" class=\"bcell-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">了解弥漫大B细胞淋巴瘤：实用指南\u003C/h2>\n\u003Cdiv class=\"bcell-section bcell-bg1\">\n  \u003Ch3 class=\"bcell-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 概述：弥漫大B细胞淋巴瘤是什么？\u003C/h3>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cspan class=\"bcell-emoji\">💡\u003C/span>\n    有些疾病来得安静，恍若日常小麻烦，但背后影响深远。弥漫大B细胞淋巴瘤（DLBCL）就是一种本身发展较快的淋巴系统肿瘤，由B淋巴细胞异常繁殖造成。B淋巴细胞在人体内负责抗击外来细菌、病毒，相当于免疫小卫士。但当这些细胞增长失控，就可能演变为弥漫性大B细胞淋巴瘤。\n  \u003C/div>\n  \u003Cdiv class=\"bcell-paragraph\">\n    简单来说，DLBCL是一种常见的非霍奇金淋巴瘤，主要影响淋巴结，有时也可能“潜伏”在脾脏、肝脏等器官（Armand, P. et al., 2024）。最重要的是，这种疾病许多时候可以被治愈，但及时发现、规范治疗非常关键。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bcell-section bcell-bg2\">\n  \u003Ch3 class=\"bcell-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 明显症状：警惕这些身体信号\u003C/h3>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cspan class=\"bcell-emoji\">🩺\u003C/span>\n    某些健康问题，最开始出现时或许只有轻微不适，但如果持续变严重，就是需要警惕的信号。比如有位30岁男性，最初只有头部及右眼轻微疼痛，后来逐步出现鼻腔出血，经检查发现肿物侵及颅底，最终确诊为DLBCL。\n  \u003C/div>\n  \u003Cdiv class=\"bcell-paragraph\">\n    具体来说，DLBCL的典型表现包括：\n    \u003Cul class=\"bcell-list\">\n      \u003Cli>淋巴结肿大：通常在颈部、腋下或腹股沟，一开始或许只是偶尔发现肿块，后续如果持续变大或变硬，需要就诊。\u003C/li>\n      \u003Cli>持续发热：无明显原因的体温反复升高，不易退烧。\u003C/li>\n      \u003Cli>夜间盗汗：入睡后出汗明显，影响休息。\u003C/li>\n      \u003Cli>体重减轻：短期内体重明显下降，并非刻意减肥所致。\u003C/li>\n      \u003Cli>极度疲劳：如果原本活力正常，突然变得容易劳累，无法恢复。\u003C/li>\n    \u003C/ul>\n    这些不只是普通小病小痛，而是身体异常信号。尤其如果上述症状持续一两周以上，千万不要拖延，应该及时找医生进一步检查（Dana-Farber Cancer Institute, 2024）。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bcell-section bcell-bg3\">\n  \u003Ch3 class=\"bcell-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 可能原因：为什么会得弥漫大B细胞淋巴瘤？\u003C/h3>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cspan class=\"bcell-emoji\">🔬\u003C/span>\n    很多人关心到底是什么原因让异常细胞出现失控。其实，DLBCL不仅仅和某种坏习惯有关，而是受到多种因素的共同作用。\n  \u003C/div>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Col class=\"bcell-list\">\n      \u003Cli>\n        \u003Cb>免疫系统失调\u003C/b>：免疫力缺陷的人群，例如有慢性免疫疾病或长期使用免疫抑制药物的人，风险会更高。这是因为人体防线减弱，异常细胞更容易失控。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>遗传易感\u003C/b>：有家族史的人群在发病上略有优势，虽然不是绝对因素，但基因对细胞分裂失序有一定影响。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>年龄因素\u003C/b>：发病率随年龄增长而提升。医学统计，一半患者超过60岁，但也有年轻患者（如前述30岁男性病例）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>环境因素\u003C/b>：长期接触有害化学物质、病毒感染（例如EB病毒）、某些慢性炎症，也可能增加患病概率。\n      \u003C/li>\n    \u003C/ol>\n    研究显示，无论性别、职业、生活环境，弥漫大B细胞淋巴瘤都不是离我们很远的疾病（Shipp, M.A., et al., 2023）。\n    \u003Cbr>\n    \u003Cspan style=\"font-weight: 500;\">这提醒我们：\u003C/span>预防无法做到百分百，但了解这些风险，有助于提高警觉性。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bcell-section bcell-bg4\">\n  \u003Ch3 class=\"bcell-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 如何诊断弥漫大B细胞淋巴瘤？\u003C/h3>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cspan class=\"bcell-emoji\">🧪\u003C/span>\n    说起来，DLBCL的确诊要比普通体检复杂一些。临床上最关键的是针对呆在体内的异常细胞做精确检查。\n  \u003C/div>\n  \u003Cdiv class=\"bcell-paragraph\">\n    具体流程包括：\n    \u003Cul class=\"bcell-list\">\n      \u003Cli>\u003Cb>体格检查\u003C/b>：医生会仔细检查身体各部位淋巴结有无肿大或异常。\u003C/li>\n      \u003Cli>\u003Cb>影像学检查\u003C/b>：如CT、PET-CT，可以“看到”淋巴组织分布和是否侵及其他器官。\u003C/li>\n      \u003Cli>\u003Cb>病理活检\u003C/b>：对异常组织取一小块，放在显微镜下分析，这是诊断的金标准。\u003C/li>\n      \u003Cli>\u003Cb>血液学检查\u003C/b>：包括血常规、淋巴细胞亚群等，筛查身体其他潜在异常。\u003C/li>\n      \u003Cli>\u003Cb>遗传分型\u003C/b>：新技术有助于确定具体亚型，支持个体化治疗。\u003C/li>\n    \u003C/ul>\n    从临床来看，许多患者出现淋巴结肿大或持续发热时，医生会优先考虑上述流程。而且这些检查不止用于首次发现，还用于后续治疗和复查（Armand, P. et al., 2024）。\n    \u003Cbr>\n    \u003Cspan style=\"font-weight: 500;\">建议：\u003C/span>如果存在上述异常，尽快前往有肿瘤专科资质的医院检查。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bcell-section bcell-bg5\">\n  \u003Ch3 class=\"bcell-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 治疗方案：如何应对弥漫大B细胞淋巴瘤？\u003C/h3>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cspan class=\"bcell-emoji\">🛠️\u003C/span>\n    针对DLBCL，目前医学界主流的治疗以化疗、靶向和免疫疗法为主，标准方案有一定共识，但要根据每个人实际病情调整。\n  \u003C/div>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cul class=\"bcell-list\">\n      \u003Cli>\n        \u003Cb>化疗（R-CHOP）\u003C/b>：包括多种药物联合，能较好控制肿瘤，副作用包括骨髓抑制、脱发等，不过大多数患者能耐受，疗效较好（POLARIX Clinical Trial, Tilly H., et al., 2022）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>靶向治疗\u003C/b>：新型药物，如波拉妥单抗联合化疗，对部分耐药患者有希望，副作用较为温和。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>免疫治疗\u003C/b>：如CAR T细胞疗法，对复发或难治型有效，但费用和技术要求较高，适合特定人群。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>自体干细胞移植\u003C/b>：针对复发或治疗反应不佳者，属于后线选择。\n      \u003C/li>\n    \u003C/ul>\n    实际上，每个人用药方案都不一样，如前述病例因治疗期间骨髓抑制，需要专门支持治疗和调整方案。多数患者经过合理治疗，能基本控制病情，恢复日常生活质量。\n    \u003Cbr>\n    \u003Cspan style=\"font-weight: 500;\">小提醒：\u003C/span>治疗过程中若有不适，及时与医生沟通，不必讳疾忌医。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bcell-section bcell-bg6\">\n  \u003Ch3 class=\"bcell-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 实用生活建议：饮食、运动与心理支持\u003C/h3>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cspan class=\"bcell-emoji\">🥗\u003C/span>\n    没有完美的防护网，但好习惯可以帮助身体应对风险。这里给出一些能切实提升免疫力和日常健康的生活策略。\n  \u003C/div>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cul class=\"bcell-list\">\n      \u003Cli>\n        \u003Cb>多吃新鲜蔬菜和水果\u003C/b>：富含维生素C，有助于维护免疫屏障，建议每天均衡摄入，色彩丰富是加分项。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>优质蛋白摄入\u003C/b>：如鸡蛋、瘦肉、豆制品等，有助细胞修复。推荐每餐都适量加入优质蛋白食物。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>饮水充足\u003C/b>：保持每天1500-2000ml水分摄入，有助体内代谢及消化系统健康。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>适度运动\u003C/b>：如散步、慢跑，每周3-4次，每次30分钟即可，能激活免疫活力，也对情绪管理很有效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cb>关注心情问题\u003C/b>：面临疾病时，心理疏导非常重要。和家人聊天、参加心理咨询、加入互助群体都有帮助。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cspan style=\"font-weight: 500;\">如果出现持续不适（如长期咽痛、体重短期大幅下降等），一定要及时就医。\u003C/span>\n    \u003Cbr>\n    简单来说，每个人都可以在吃、动、心三个方面多用点心思，对整体健康大有好处。\n  \u003C/div>\n\u003C/div>\n\n\u003Cdiv class=\"bcell-section bcell-bg7\">\n  \u003Ch3 class=\"bcell-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 结语：温和关注，积极面对\u003C/h3>\n  \u003Cdiv class=\"bcell-paragraph\">\n    弥漫大B细胞淋巴瘤听起来离我们很远，但其实无论年龄、性别，都需要了解相关知识。科学的健康管理习惯，就是抵御“异常细胞不速之客”的最佳方式。正如病例所示，即使确诊后，通过规范治疗，也能恢复稳定生活。对于症状发现、检查治疗和饮食管理，保持平常心、积极面对是应对疾病的根本。\n    \u003Cbr>\n    最好的办法还是那句话：有问题别拖，及时求助专业医生，日常生活中多注意身体变化，把握健康主动权。\n  \u003C/div>\n  \u003Cdiv class=\"bcell-paragraph\">\n    \u003Cspan class=\"bcell-emoji\">📚\u003C/span>\n    参考文献：\n    \u003Cul class=\"bcell-ref-list\">\n      \u003Cli>Armand, P., et al. (2024). Diffuse Large B-Cell Lymphoma: What You Need to Know. Dana-Farber Cancer Institute. Boston, MA.\u003C/li>\n      \u003Cli>Tilly, H., et al. (2022). Pola-R-CHP versus R-CHOP in DLBCL: Outcomes from the POLARIX trial. New England Journal of Medicine, 386(2), 123-133.\u003C/li>\n      \u003Cli>Shipp, M.A., et al. (2023). Genetic subtypes of DLBCL and implications for therapy. Nature Reviews Cancer, 23(7), 452-464.\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.bcell-title {\n  font-size: 32px;\n  font-weight: bold;\n  margin: 28px 0 22px 0;\n  text-align: center;\n  color: #144067;\n  letter-spacing: 1px;\n}\n.bcell-section {\n  border-radius: 16px;\n  box-shadow: 0 4px 20px 0 rgba(20, 64, 103, 0.06);\n  padding: 38px 32px 32px 32px;\n  margin-bottom: 32px;\n  max-width: 900px;\n  margin-left: auto;\n  margin-right: auto;\n}\n.bcell-subtitle {\n  font-size: 24px;\n  font-weight: 600;\n  color: #17637b;\n  margin-bottom: 18px;\n  letter-spacing: 0.5px;\n  text-align: left;\n}\n.bcell-paragraph {\n  font-size: 19px;\n  line-height: 1.75;\n  color: #33475b;\n  margin-bottom: 16px;\n}\n.bcell-emoji {\n  font-size: 22px;\n  margin-right: 8px;\n}\n.bcell-list {\n  margin: 8px 0 12px 28px;\n  padding: 0;\n  list-style-type: disc;\n  font-size: 18px;\n  color: #3b525b;\n}\n.bcell-list b {\n  color: #17637b;\n  font-weight: 500;\n}\n.bcell-ref-list {\n  margin: 10px 0 0 24px;\n  font-size: 16px;\n  color: #1b3769;\n}\n.bcell-bg1, .bcell-bg2, .bcell-bg3, .bcell-bg4, .bcell-bg5, .bcell-bg6, .bcell-bg7 {\n  position: relative;\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n.bcell-bg1 {background: linear-gradient(90deg, #f7fafd 50%, #e6f6ff 100%);}\n.bcell-bg2 {background: linear-gradient(105deg, #f9f5fc 60%, #fcfefd 100%);}\n.bcell-bg3 {background: linear-gradient(90deg, #edf7fa 70%, #e3f2fd 100%);}\n.bcell-bg4 {background: linear-gradient(100deg, #f6fcfb 80%, #e6f9f3 100%);}\n.bcell-bg5 {background: linear-gradient(96deg, #fcf8f7 70%, #ffeaea 100%);}\n.bcell-bg6 {background: linear-gradient(100deg, #f7fafd 90%, #e5f6fa 100%);}\n.bcell-bg7 {background: linear-gradient(90deg, #f5fafd 92%, #e4f4f9 100%);}\n@media (max-width: 700px) {\n  .bcell-section {\n    padding: 20px 12px 16px 12px;\n  }\n  .bcell-title {\n    font-size: 23px;\n  }\n  .bcell-subtitle {\n    font-size: 17px;\n  }\n  .bcell-paragraph, .bcell-list {\n    font-size: 15px;\n  }\n}\n\u003C/style>\n","\u003Ch2 id=\"material_title\" class=\"bcell-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; ",514,"2025-08-18 11:10:22","弥漫大B细胞淋巴瘤, DLBCL, 淋巴瘤症状, 免疫系统, 治疗方案","弥漫大B细胞淋巴瘤(DLBCL)是常见的淋巴肿瘤，及时发现和治疗非常关键。本文为你提供症状、原因、诊断及治疗方案，帮助你掌握健康主动权。","2025-08-20 12:05:16",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]